Nguyen-Tran, H., Park, S. W., Messacar, K., Dominguez, S. R., Vogt, M. R., Permar, S., … Spaulding, A. B. (2022). Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens. The Lancet Microbe, 3(2), e83–e85. https://doi.org/10.1016/S2666-5247(21)00312-8

Nguyen-Tran, H., S. W. Park, K. Messacar, S. R. Dominguez, M. R. Vogt, S. Permar, P. Permaul, et al. “Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens.” The Lancet Microbe 3, no. 2 (February 1, 2022): e83–85. https://doi.org/10.1016/S2666-5247(21)00312-8.

Nguyen-Tran H, Park SW, Messacar K, Dominguez SR, Vogt MR, Permar S, et al. Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens. The Lancet Microbe. 2022 Feb 1;3(2):e83–5.

Nguyen-Tran, H., et al. “Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens.” The Lancet Microbe, vol. 3, no. 2, Feb. 2022, pp. e83–85. Scopus, doi:10.1016/S2666-5247(21)00312-8.

Nguyen-Tran H, Park SW, Messacar K, Dominguez SR, Vogt MR, Permar S, Permaul P, Hernandez M, Douek DC, McDermott AB, Metcalf CJE, Grenfell B, Spaulding AB. Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens. The Lancet Microbe. 2022 Feb 1;3(2):e83–e85.